Ag Companies Resolve Court Case

Corteva raised its FY2026 outlook after strong first-half performance, driven by demand for premium seed genetics and resilient crop protection sales. Net sales increased 4%, with GAAP income of $1.94B and EPS of $2.88. The company plans to separate into two businesses, with separation costs expected to be offset by long-term efficiencies. Corteva projects Operating EBITDA of $4.1B-$4.3B and Operating EPS of $3.60-$3.80 for the full year.

Illinois and the FTC reached a $35M settlement with Corteva Inc. over allegations of blocking generic pesticide competitors. Corteva must dismantle its loyalty program and is barred from similar practices for 10 years. Illinois will return $7.5M to affected farmers. The settlement aims to lower pesticide prices for farmers.

Vylor Inc. officially splits from Corteva Agriscience on Oct. 1, moving its headquarters to Johnston, Iowa. The $22B seed company will focus on AI and gene editing, investing $1.2B annually in R&D. Legal challenges from California over PFAS liability remain pending. Vylor aims to address global food and weather challenges, with plans to release new disease-resistant corn hybrids. Corteva denies PFAS allegations, stating the split does not put it in financial danger.

Corteva Inc. and Inari Agriculture settled a patent dispute over seed materials. Inari must destroy Corteva's biological materials and assign related IP to Corteva. The settlement includes future licensing negotiations. Corteva is also restructuring, separating its seed and crop protection businesses. Financial terms were not disclosed. The case highlights IP protections in agricultural innovation.

Corteva Inc. will pay $35 million to settle an antitrust lawsuit filed by the FTC and 12 states, including Oregon and Washington. The company will also discontinue a rebate program that allegedly stifled competition from generic products, costing farmers millions annually. The settlement allows states to distribute funds, with Nebraska and Illinois pursuing monetary damages. Syngenta, also sued, continues to defend its practices.

Corteva and Inari settled a $1.3B seed patent dispute mid-trial in Delaware. The case involved questions about IP protections for biological materials and patent rights balance. The settlement terms were not disclosed.